Pfizer projects 2025 revenue growth up to $64 billion
Pfizer Inc. (NYSE:PFE) has issued its financial guidance for the full year 2025, projecting revenue growth between $61 billion and $64 billion, representing a flat...
Tag : oncology
Merck and Daiichi Sankyo forge $5.5 billion cancer drug alliance
Merck, a global pharmaceutical giant, has inked a partnership with Japanese firm Daiichi Sankyo, valuing at $5.5 billion, to co-develop three advanced cancer therapies. Depending...